Vitamin D receptor gene polymorphism and ulcerative colitis susceptibility in Han Chinese

Journal of Digestive Diseases

Volumn 12, Issue 2, 2011, Pages 90-98

  Pei, Feng Hua ^a,c   Wang, Yan Jun ^b   Gao, Shan Ling ^c   Liu, Bing Rong ^c   Du, Ya Ju ^c   Liu, Wei ^c   Yu, Hong Ying ^c   Zhao, Li Xia ^c   Chi, Bao Rong ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Han Chinese; Polymorphism; Ulcerative colitis; Vitamin D receptor gene

Indexed keywords

VITAMIN D RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHINESE; COLITIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; EXTENSIVE COLITIS; FEMALE; GENDER; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LEFT SIDED COLITIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCTITIS; PROCTOSIGMOIDITIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL; YOUNG ADULT;

EID: 79952668965     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2011.00483.x     Document Type: Article

References (52)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-29.
2. Martin K, Radlmayr M, Borchers R, Heinzlmann M, Folwaczny C. Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion 2002; 66: 121-6.
3. Rodríguez-Bores L, Fonseca GC, Villeda MA, Yamamoto-Furusho JK. Novel genetic markers in inflammatory bowel disease. World J Gastroenterol 2007; 42: 5560-70.
4. Lesage S, Zouali H, Cezard JP etal. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 845-57.
5. Rosenstiel P, Fantini M, Brautigam K etal. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003; 124: 1001-9.
6. Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 2007; 30: 5-15.
7. Curran ME, Lau KF, Hampe J etal. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology 1998; 115: 1066-71.
8. Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-Le-Grand) 2003; 49: 277-300.
9. Yu S, Bruce D, Froicu M, Weaver V, Cantorna MT. Failure of T cell homing, reduced CD4/CD8 alpha alpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci USA 2008; 105: 20834-9.
10. Stio M, Martinesi M, Bruni S etal. Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients. Int Immunopharmacol 2006; 6: 1083-92.
11. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338: 143-56.
12. Kiehne K, Brunke G, Wegner F, Banasiewicz T, Folsch UR, Herzig KH. Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. World J Gastroenterol 2006; 12: 1056-62.
13. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004; 229: 1136-42.
14. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1, 25-Dihy droxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000; 130: 2648-52.
15. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003; 17: 2386-92.
16. Kong J, Zhang Z, Musch MW etal. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2008; 294: G208-16.
17. Morrison NA, Qi JC, Tokita A etal. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-7.
18. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 1996; 11: 1850-55.
19. Wood RJ, Fleet JC. The genetics of osteoporosis: vitamin D receptor polymorphisms. Annu Rev Nutr 1998; 18: 233-58.
20. Ingles SA, Ross RK, Yu MC etal. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997; 89: 166-70.
21. Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol 1998; 16: 593-617.
22. Naderi N, Farnood A, Habibi M etal. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol 2008; 23: 1816-22.
23. Dresner-Pollak R, Ackerman Z, Eliakim R, Karban A, Chowers Y, Fidder HH. The Bsm I vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients. Genet Test 2004; 8: 417-20.
24. Simmons JD, Mullighan C, Welsh KI, Jewell DP. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 2000; 47: 211-14.
25. The cooperation group IBD of Chinese Medical Association Digestive Branch. Chinese consensus on diagnosis and treatment standard of inflammatory bowel disease. Chin J Dig 2007; 12: 488-95 (in Chinese).
26. Schwartz BS, Lee BK, Lee GS etal. Association of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect 2000; 108: 949-54.
27. Tokita A, Matsumoto H, Morrison NA etal. Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res 1996; 11: 1003-9.
28. Lim SK, Park YS, Park JM etal. Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans. J Clin Endocrinol Metab 1995; 80: 3677-81.
29. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc Natl Acad Sci USA 1992; 89: 6665-69.
30. Hustmyer FG, Deluca HF, Peacock M. ApaI, BsmI, EcoRV and TaqI polymorphism at the human vitamin D receptor gene locus in Caucasians, Blacks and Asians. Hum Mol Genet 1993; 2: 487.
31. Leng S, Song W, Wang Y etal. Analysis of vitamin D receptor gene polymorphisms in 538 Chinese Han nationality. Chin J Prev Med 2002; 36: 314 (in Chinese).
32. Zhang H, Tao G, Gao Y etal. Studies on the distribution of vitamin D receptor gene polymorphism in Han, Uygur, Kazak and Mongoloid nationality in. China Chin J Osteoporos 2006; 12: 1-3 (in Chinese).
33. Martin K, Radlmayr M, Borchers R, Heinzlmann M, Folwaczny C. Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion 2002; 66: 121.
34. Naderi N, Farnood A, Habibi M etal. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol 2008; 23: 1816-22.
35. Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 2006; 371: 1-12.
36. Ingles SA, Haile RW, Henderson BE etal. Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev 1997; 6: 93-8.
37. Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000; 22: 203-17.
38. Whitfield GK, Remus LS, Jurutka PW etal. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 2001; 177: 145-59.
39. Morrison NA, Qi JC, Tokita A etal. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-7.
40. Carling T, Rastad J, Akerstrom G, Westin G. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 1998; 83: 2255-9.
41. DeLuca HF. Vitamin D. Nutr Today 1993; 28: 6-11.
42. Clemens TL, Adams JS, Nolan JM, Holick MF. Measurement of circulating vitamin D in man. Clin Chim Acta 1982; 121: 301-8.
43. Fleming CR. Nutrition in patients with Crohn's disease: another piece of the puzzle. JPEN J Parenter Enteral Nutr 1995; 19: 93-4.
44. Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 1998; 67: 919-26.
45. Andreassen H, Rungby J, Dahlerup JF, Mosekilde L. Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol 1997; 32: 1247-55.
46. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003; 17: 2386-92.
47. Akutsu N, Lin R, Bastien Y etal. Regulation of gene expression by 1alpha, 25-dihydroxyvitamin D3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma cells. Mol Endocrinol 2001; 15: 1127-39.
48. Jiang F, Li P, Fornace AJ Jr, Nicosia SV, Bai W. G2/M arrest by 1, 25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J Biol Chem 2003; 278: 48030-40.
49. Khanim FL, Gommersall LM, Wood VH etal. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene 2004; 23: 6712-25.
50. Palmer HG, Gonzalez-Sancho JM, Espada J etal. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001; 154: 369-87.
51. Sinotte M, Rousseau F, Ayotte P etal. Vitamin D receptor polymorphisms (Fok I Bsm I) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocr Relat Cancer 2008; 15: 975-83.
52. Randerson Moor JA, Taylor JC, Elliott F etal. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer 2009; 45: 3271-81.